Qube Research & Technologies (QRT)
BMY icon

Qube Research & Technologies (QRT)’s Bristol-Myers Squibb BMY Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$194M Buy
3,203,665
+772,565
+32% +$45M 0.22% 96
2025
Q4 		$131M Sell
2,431,100
-5,682,274
-70% -$273M 0.13% 163
2025
Q3 		$366M Sell
8,113,374
-1,639,309
-17% -$76.6M 0.38% 39
2025
Q2 		$451M Buy
+9,752,683
New +$479M 0.46% 24
2024
Q3 		– Sell
-4,690,379
Closed -$220M – 3347
2024
Q2 		$195M Buy
4,690,379
+1,498,953
+47% +$67.1M 0.31% 59
2024
Q1 		$173M Sell
3,191,426
-3,503,168
-52% -$178M 0.27% 81
2023
Q4 		$343M Buy
6,694,594
+3,208,186
+92% +$168M 0.67% 11
2023
Q3 		$202M Buy
3,486,408
+1,035,243
+42% +$63.4M 0.53% 29
2023
Q2 		$157M Buy
2,451,165
+1,986,534
+428% +$133M 0.57% 21
2023
Q1 		$32.2M Sell
464,631
-986,386
-68% -$69.6M 0.14% 163
2022
Q4 		$104M Buy
+1,451,017
New +$109M 0.56% 16
2022
Q3 		– Sell
-1,070,359
Closed -$82.4M – 2528
2022
Q2 		$82.4M Buy
1,070,359
+1,021,867
+2,107% +$77.8M 0.61% 24
2022
Q1 		$3.54M Buy
+48,492
New +$3.26M 0.03% 611
2021
Q4 		– Sell
-235,469
Closed -$13.9M – 2538
2021
Q3 		$13.9M Buy
+235,469
New +$15.5M 0.17% 137
2021
Q2 		– Sell
-325,357
Closed -$20.5M – 2283
2021
Q1 		$20.5M Buy
325,357
+294,817
+965% +$18.3M 0.33% 39
2020
Q4 		$1.89M Buy
30,540
+24,717
+424% +$1.52M 0.03% 641
2020
Q3 		$351K Buy
5,823
+1,606
+38% +$96.7K 0.01% 1171
2020
Q2 		$248K Buy
+4,217
New +$252K ﹤0.01% 1366
2019
Q2 		– Sell
-60,669
Closed -$2.9M – 416
2019
Q1 		$2.9M Buy
+60,669
New +$3.02M 0.38% 59
2018
Q4 		– Sell
-21,221
Closed -$1.32M – 365
2018
Q3 		$1.32M Buy
21,221
+19,108
+904% +$1.13M 0.18% 98
2018
Q2 		$117K Sell
2,113
-1,647
-44% -$89K 0.07% 276
2018
Q1 		$237K Buy
+3,760
New +$242K 0.09% 137

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BMY Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Bristol-Myers Squibb (BMY) stake by 32% in Q1 2026, buying an estimated $45M and bringing the position to 3,203,665 shares worth $194M. The position accounts for 0.22% of the portfolio, ranked #96.

Qube Research & Technologies (QRT) first reported a position in BMY in Q1 2018 and has held it in 22 quarters since. The position peaked at $451M in Q2 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Qube Research & Technologies (QRT) held 3,203,665 shares of Bristol-Myers Squibb worth $194M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 772,565 Bristol-Myers Squibb shares in Q1 2026, an estimated $45M.
  • Bristol-Myers Squibb made up 0.22% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #96 holding.
  • Qube Research & Technologies (QRT) first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 22 quarters since.
  • Qube Research & Technologies (QRT)'s Bristol-Myers Squibb position peaked at $451M in Q2 2025.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.